[Drug sensitivity of the so-called atypical mycobacteria].
D000636:Aminosalicylic Acids / Q000494:pharmacology; D000995:Antitubercular Agents / Q000494:pharmacology*; D003523:Cycloserine / Q000494:pharmacology; D004352:Drug Resistance, Microbial; D004977:Ethambutol / Q000494:pharmacology; D005000:Ethionamide / Q000494:pharmacology; D066298:In Vitro Techniques; D007538:Isoniazid / Q000494:pharmacology; D007612:Kanamycin / Q000494:pharmacology; D008826:Microbial Sensitivity Tests; D009025:Morpholines / Q000494:pharmacology*; D009161:Mycobacterium / Q000145:classification / Q000187:drug effects*; D011718:Pyrazinamide / Q000494:pharmacology; D011719:Pyrazines / Q000494:pharmacology; D012293:Rifampin / Q000494:pharmacology; D013307:Streptomycin / Q000494:pharmacology; D014756:Viomycin / Q000494:pharmacology
D000636:Aminosalicylic Acids; D000995:Antitubercular Agents; D009025:Morpholines; D011719:Pyrazines; D011718:Pyrazinamide; D007612:Kanamycin; D004977:Ethambutol; D003523:Cycloserine; D005000:Ethionamide; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin; D014756:Viomycin
La farmaco-sensibilità dei micobatteri cosiddetti "atipici".